publication venue for
- Decoding the metabolic landscape of pathophysiological stress-induced cell death in anucleate red blood cells.. 18:130-142. 2020
- A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.. 17:391-398. 2019
- Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.. 14:66-72. 2016
- The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes.. 13:559-568. 2015
- The haemophilia certification system in Canada.. 12 Suppl 3:e531-e541. 2014
- The national haemophilia program standards, evaluation and oversight systems in the United States of America.. 12 Suppl 3:e542-e548. 2014
- Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials.. 11:533-540. 2013
- Haemophilia at various stages of life: design of new therapeutic strategies through an interactive course--the Kogeniale project.. 11:272-280. 2013
- Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy.. 9:60-69. 2011
- Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase.. 6:211-219. 2008
- The good use of plasma. A critical analysis of five international guidelines.. 6:18-24. 2008